WHO sets a 2035 roadmap for hypertension in pregnancy
The global plan connects research, clinical standards, medicines, diagnostics and health-system delivery across the next decade.
AI & data · Published 9 October 2026
WHO asks how AI is actually being used in family planning
The scoping review seeks practice-based evidence from governments, civil society and implementers, not only peer-reviewed papers.
Read the briefing ↗The briefing
What changed for women.
What it means.
Independent women’s-health reporting on what changed, why it matters and what to watch next.
A 6.1M-person pain study gives women’s pain a global benchmark
Nature Medicine reference curves show women reported higher pain prevalence than men across all 11 anatomical sites studied.
WHO says violence is shaping adolescent girls’ health before adulthood
A new analysis estimates about 43 million girls aged 15–19 have experienced intimate-partner violence, non-partner sexual violence, or both.
Fetal DNA biology may be the next prenatal-testing frontier
A Science Advances review argues NIPT technology has outpaced knowledge of how fetal DNA circulates in maternal blood.
Health & science
Evidence before excitement.
Research, medicine and technology—reported with the limits, source and unanswered questions intact.
WHO asks how AI is actually being used in family planning
The scoping review seeks practice-based evidence from governments, civil society and implementers, not only peer-reviewed papers.
A 6.1M-person pain study gives women’s pain a global benchmark
Nature Medicine reference curves show women reported higher pain prevalence than men across all 11 anatomical sites studied.
Fetal DNA biology may be the next prenatal-testing frontier
A Science Advances review argues NIPT technology has outpaced knowledge of how fetal DNA circulates in maternal blood.
Policy & society
The system shapes the outcome.
Policy, rights, regulation, care delivery and the decisions that determine who gains access.
WHO sets a 2035 roadmap for hypertension in pregnancy
The global plan connects research, clinical standards, medicines, diagnostics and health-system delivery across the next decade.
WHO says violence is shaping adolescent girls’ health before adulthood
A new analysis estimates about 43 million girls aged 15–19 have experienced intimate-partner violence, non-partner sexual violence, or both.
FDA gives Lynkuet priority review for breast-cancer-treatment hot flashes
The supplemental application concerns vasomotor symptoms linked to endocrine therapy; priority review shortens the review goal but is not approval.
From the archive
The innovation file starts in January 2025.
Historical briefings use the source or event date and are clearly marked as archive reporting.
Explore 16 archive briefings ↗
EndoSure gains a European CE mark—but its evidence questions are not settled
The non-invasive endometriosis test can be marketed in the EU, while US use remains research-only and independent clinical validation is still limited.
The endometriosis peptide ENDO-205 can now begin human testing
FDA clearance of an investigational application allows a planned Phase 1 study to proceed; it is not approval of the treatment, and no human efficacy data have been reported.
FDA approves the first generic low-dose estradiol vaginal insert
The generic version of Imvexxy adds another potential access route for painful sex associated with menopausal vulvar and vaginal atrophy.
WHO issues its first global guideline on infertility care
Forty recommendations address prevention, diagnosis, staged treatment, psychosocial support and the affordability of fertility care.